US2021085783A1PendingUtilityA1

Predilution sets for distributing antigens

Assignee: ROCA MEDICAL LTDPriority: Jun 2, 2015Filed: Jun 30, 2020Published: Mar 25, 2021
Est. expiryJun 2, 2035(~8.8 yrs left)· nominal 20-yr term from priority
A61K 39/00A61K 39/35
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for delivering allergens to a pharmacist in a pre-diluted kit form, comprising providing a bulk container of base concentrate antigen containing at least one antigen at a predetermined concentrated level, creating a sequential and more diluted sequence of antigens, providing a plurality of end-use sealable containers that can receive a finite end amount of diluted antigens, dispensing from each of sequential bulk containers a finite end amount of diluted antigens into one of the plurality of end-use sealable containers, wherein the end-use seal containers filled from each of the sequential bulk containers comprises a group of end-use sealable containers associated with each of the sequential bulk containers, sealing each of the end-use containers after diluted antigens are disposed therein, and disposing a select number of the sealed end-use sealable containers from each of the groups of end-use sealable containers into a container comprising a kit.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A prediluted kit including a range of prediluted doses of allergens for dispensing to a patient, comprising:
 a container having a plurality of receiving pockets, each being associated with one of a plurality of sequential diluted allergen levels all based on a base concentrate antigen wherein the base concentrate antigen includes at least one specific antigen;   a plurality of end-use sealable containers of prediluted antigens,   wherein the plurality of end-use sealable containers are sterile,   wherein each one of the plurality of end-use sealable containers is at a defined level and disposed in one of the plurality of receiving pockets,   wherein each one of the plurality of end-use sealable containers is prepackaged as already including the base concentrate antigen at a sequential dilution level diluted in accordance with a predetermined sequential dilution process to provide sequentially lower dilution levels for use in an allergy desensitization regimen prescribed by a medical professional, and   wherein each one of the plurality of end-use sealable containers includes at least one insert operable to:
 provide an elongated interior in the end-use sealable container, the elongated interior having a volume corresponding to at least a dose; and 
 fill space within the end-use sealable container to dispose a prediluted antigen at an elevated level in the end-use sealable container for extraction; and 
   an indicator disposed in association with each of the plurality of receiving pockets indicating the dilution level of the associated one of the end-use sealable containers included therein.

Join the waitlist — get patent alerts

Track US2021085783A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.